okredo logo
none title certification

UAB "Swixx Biopharma" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

EBITDA margin (%)

Login to see the data

EBIT margin (%)

Login to see the data
Financial report background

Financial statetment report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
Working capital requirementinfo
Debt-to-equity ratioinfo
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2021
2,011,147
139,663
102,953
84,739
5,885
83.74
4.21
338,675
391,148
101,251
610,765
2022
5,166,407
127,786
301,363
264,118
6,533
84.06
5.11
602,793
580,246
96,663
1,035,103
2023
5,786,464
138,797
381,645
302,989
7,268
84.57
5.24
905,783
769,783
109,242
1,466,233
unlock data icon

Register and

explore Okredo data
2023
5,786,464
138,797
381,645
302,989
7,268
84.57
5.24
905,783
769,783
109,242
1,466,233
unlock data icon

Register and

explore Okredo data

2023

Turnover (€)

5,786,464 €Ascended12 % *

Sales per employee (€)

138,797 €Ascended9 % *

Profit before tax (€)

381,645 €Ascended27 % *

Net Profit (€)

302,989 €Ascended15 % *

Profit per employee (€)

7,268 €Ascended11 % *

Total profitability (%)

84.57 %Ascended0.61 % *

Net profitability (%)

5.24 %Ascended2.54 % *

Equity (€)

905,783 €Ascended50 % *

Amounts Payable And Liabilities (€)

769,783 €Ascended33 % *

Non-current Assets (€)

109,242 €Ascended13 % *

CurrentAssets (€)

1,466,233 €Ascended42 % *

*over the last year starting selected period